Review



brd4 bromodomain plasmid  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    Addgene inc brd4 bromodomain plasmid
    (A) Chemical structure of the JQ1-oligo-Cy5 conjugate used as a fluorescent probe (BP). JQ1, a selective <t>BRD4</t> ligand, is covalently linked to a DNA oligonucleotide and a Cy5 fluorophore, allowing fluorescence-based detection of BRD4 binding. (B) Schematic illustrations (top) and corresponding fluorescence images (bottom) of agarose μ-droplets containing magnetic beads only, BRD4-bound magnetic beads, agarose alone, intact HeLa cells, or permeabilized HeLa cells after incubation with JQ1-oligo-Cy5. Strong Cy5 fluorescence was observed in droplets containing BRD4-bound magnetic beads and permeabilized HeLa cells, whereas no detectable Cy5 fluorescence was observed in magnetic beads only, intact HeLa cells, and agarose-only droplets. Scale bars, 50μm. (C) Schematic illustration of two-color Exchange-PAINT imaging using orthogonal DNA docking-imager strand pairs. An R6 docking strand conjugated to an anti-GFP nanobody was used to label GFP-BRD4, while an R2 docking strand was incorporated into the JQ1-based probe (JQ1-BP). Sequential super-resolution imaging was performed using R6* and R2* imager strands to independently localize BRD4 and bound JQ1, respectively. (D) Two-color Exchange-PAINT super-resolution images of GFP-BRD4-expressing Cos7 cells showing GFP-BRD4 (green) and the JQ1-based probe (JQ1-BP, red). Left, whole-nucleus view; middle, magnified view of the boxed region highlighting nanoscale clustering of BRD4 and JQ1. Right, the same region after Q-PAINT-based cluster filtering (K > 10), revealing higher-order nanoclusters containing both BRD4 and JQ1. Enrichment of JQ1-BP localizations at GFP-BRD4 clusters indicates that JQ1 preferentially localizes to BRD4-enriched nuclear regions.
    Brd4 Bromodomain Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromodomains/GFP-BRD4+(Plasmid+%2365378)/bio_rxiv__64898__2026__02__15__706034-167-1-17
    Average 91 stars, based on 10 article reviews
    brd4 bromodomain plasmid - by Bioz Stars, 2026-10
    91/100 stars

    Images

    1) Product Images from "Microfluidic Agarose µ -Droplets for DNA-Encoded Chemical Library Screening"

    Article Title: Microfluidic Agarose µ -Droplets for DNA-Encoded Chemical Library Screening

    Journal: bioRxiv

    doi: 10.64898/2026.02.15.706034

    (A) Chemical structure of the JQ1-oligo-Cy5 conjugate used as a fluorescent probe (BP). JQ1, a selective BRD4 ligand, is covalently linked to a DNA oligonucleotide and a Cy5 fluorophore, allowing fluorescence-based detection of BRD4 binding. (B) Schematic illustrations (top) and corresponding fluorescence images (bottom) of agarose μ-droplets containing magnetic beads only, BRD4-bound magnetic beads, agarose alone, intact HeLa cells, or permeabilized HeLa cells after incubation with JQ1-oligo-Cy5. Strong Cy5 fluorescence was observed in droplets containing BRD4-bound magnetic beads and permeabilized HeLa cells, whereas no detectable Cy5 fluorescence was observed in magnetic beads only, intact HeLa cells, and agarose-only droplets. Scale bars, 50μm. (C) Schematic illustration of two-color Exchange-PAINT imaging using orthogonal DNA docking-imager strand pairs. An R6 docking strand conjugated to an anti-GFP nanobody was used to label GFP-BRD4, while an R2 docking strand was incorporated into the JQ1-based probe (JQ1-BP). Sequential super-resolution imaging was performed using R6* and R2* imager strands to independently localize BRD4 and bound JQ1, respectively. (D) Two-color Exchange-PAINT super-resolution images of GFP-BRD4-expressing Cos7 cells showing GFP-BRD4 (green) and the JQ1-based probe (JQ1-BP, red). Left, whole-nucleus view; middle, magnified view of the boxed region highlighting nanoscale clustering of BRD4 and JQ1. Right, the same region after Q-PAINT-based cluster filtering (K > 10), revealing higher-order nanoclusters containing both BRD4 and JQ1. Enrichment of JQ1-BP localizations at GFP-BRD4 clusters indicates that JQ1 preferentially localizes to BRD4-enriched nuclear regions.
    Figure Legend Snippet: (A) Chemical structure of the JQ1-oligo-Cy5 conjugate used as a fluorescent probe (BP). JQ1, a selective BRD4 ligand, is covalently linked to a DNA oligonucleotide and a Cy5 fluorophore, allowing fluorescence-based detection of BRD4 binding. (B) Schematic illustrations (top) and corresponding fluorescence images (bottom) of agarose μ-droplets containing magnetic beads only, BRD4-bound magnetic beads, agarose alone, intact HeLa cells, or permeabilized HeLa cells after incubation with JQ1-oligo-Cy5. Strong Cy5 fluorescence was observed in droplets containing BRD4-bound magnetic beads and permeabilized HeLa cells, whereas no detectable Cy5 fluorescence was observed in magnetic beads only, intact HeLa cells, and agarose-only droplets. Scale bars, 50μm. (C) Schematic illustration of two-color Exchange-PAINT imaging using orthogonal DNA docking-imager strand pairs. An R6 docking strand conjugated to an anti-GFP nanobody was used to label GFP-BRD4, while an R2 docking strand was incorporated into the JQ1-based probe (JQ1-BP). Sequential super-resolution imaging was performed using R6* and R2* imager strands to independently localize BRD4 and bound JQ1, respectively. (D) Two-color Exchange-PAINT super-resolution images of GFP-BRD4-expressing Cos7 cells showing GFP-BRD4 (green) and the JQ1-based probe (JQ1-BP, red). Left, whole-nucleus view; middle, magnified view of the boxed region highlighting nanoscale clustering of BRD4 and JQ1. Right, the same region after Q-PAINT-based cluster filtering (K > 10), revealing higher-order nanoclusters containing both BRD4 and JQ1. Enrichment of JQ1-BP localizations at GFP-BRD4 clusters indicates that JQ1 preferentially localizes to BRD4-enriched nuclear regions.

    Techniques Used: Fluorescence, Binding Assay, Magnetic Beads, Incubation, Imaging, Expressing

    (A) Composition of the four-compound library used for proof-of-concept DEL screening, including JQ1 as a positive control, GL-CBS and methotrexate (MTX) as off-target binders, and benzoic acid as a negative control. (B) Enrichment ratios (Target / Control) derived from nanopore sequencing data following small-scale DEL screening in agarose μ-droplets containing BRD4-bound magnetic beads (target) or magnetic beads only (control). JQ1 exhibited strong enrichment above the threshold (Target / Control = 1), whereas other compounds showed minimal enrichment. (C) Quantitative analysis of small-scale DEL screening performed in cell-containing agarose μ-droplets, in which DEL enrichment was quantified by qPCR following screening. Agarose-only μ-droplets were used as a control condition, while μ-droplets containing permeabilized HeLa cells or BRD4-overexpressing HeLa cells were treated as target conditions. JQ1 showed the highest enrichment among tested compounds and displayed a pronounced preference for BRD4-overexpressing HeLa cells compared to permeabilized cells. Representative bright field, emGFP, and Cy5 fluorescence images are shown on the right. Scale bars, 50μm. emGFP fluorescence was observed specifically in BRD4-overexpressing HeLa cells. As both HeLa cell conditions were permeabilized, Cy5 fluorescence originating from BP was detected in droplets containing either permeabilized or BRD4-overexpressing HeLa cells.
    Figure Legend Snippet: (A) Composition of the four-compound library used for proof-of-concept DEL screening, including JQ1 as a positive control, GL-CBS and methotrexate (MTX) as off-target binders, and benzoic acid as a negative control. (B) Enrichment ratios (Target / Control) derived from nanopore sequencing data following small-scale DEL screening in agarose μ-droplets containing BRD4-bound magnetic beads (target) or magnetic beads only (control). JQ1 exhibited strong enrichment above the threshold (Target / Control = 1), whereas other compounds showed minimal enrichment. (C) Quantitative analysis of small-scale DEL screening performed in cell-containing agarose μ-droplets, in which DEL enrichment was quantified by qPCR following screening. Agarose-only μ-droplets were used as a control condition, while μ-droplets containing permeabilized HeLa cells or BRD4-overexpressing HeLa cells were treated as target conditions. JQ1 showed the highest enrichment among tested compounds and displayed a pronounced preference for BRD4-overexpressing HeLa cells compared to permeabilized cells. Representative bright field, emGFP, and Cy5 fluorescence images are shown on the right. Scale bars, 50μm. emGFP fluorescence was observed specifically in BRD4-overexpressing HeLa cells. As both HeLa cell conditions were permeabilized, Cy5 fluorescence originating from BP was detected in droplets containing either permeabilized or BRD4-overexpressing HeLa cells.

    Techniques Used: Drug discovery, Positive Control, Negative Control, Control, Derivative Assay, Nanopore Sequencing, Magnetic Beads, Fluorescence

    (A) Aggregated nanopore sequencing read count distributions for each core scaffold across four screening conditions: magnetic bead–only droplets, BRD4-bound magnetic bead droplets, permeabilized HeLa cell droplets, and BRD4-overexpressing HeLa cell droplets. The DNA-encoded library consisted of three distinct core scaffolds (pyrimidine, trifunctional benzene, and chiral proline cores), each comprising a 96 × 96 × 96 combinatorial spaces. (B) Three-dimensional enrichment maps for each core scaffold across the four screening conditions, displaying the top 200 BB1–BB2–BB3 combinations ranked by nanopore sequencing read count. Each axis (x, y, and z) corresponds to one building block position (BB1, BB2, and BB3), and individual points represent distinct BB1– BB2–BB3 combinations. Point color indicates read count abundance, while combinations exceeding a read count threshold of 65 are additionally highlighted by increased marker size to emphasize highly enriched species. (C) Chemical structures of the top enriched compounds identified from large-scale DEL screening. Enrichment was calculated as the ratio of nanopore sequencing read counts between target and control samples. For each core scaffold, the two compounds with the highest target-to-control enrichment are shown for both magnetic bead droplet and HeLa cell droplet screening conditions. The corresponding BB1-BB2-BB3-derived structures are displayed.
    Figure Legend Snippet: (A) Aggregated nanopore sequencing read count distributions for each core scaffold across four screening conditions: magnetic bead–only droplets, BRD4-bound magnetic bead droplets, permeabilized HeLa cell droplets, and BRD4-overexpressing HeLa cell droplets. The DNA-encoded library consisted of three distinct core scaffolds (pyrimidine, trifunctional benzene, and chiral proline cores), each comprising a 96 × 96 × 96 combinatorial spaces. (B) Three-dimensional enrichment maps for each core scaffold across the four screening conditions, displaying the top 200 BB1–BB2–BB3 combinations ranked by nanopore sequencing read count. Each axis (x, y, and z) corresponds to one building block position (BB1, BB2, and BB3), and individual points represent distinct BB1– BB2–BB3 combinations. Point color indicates read count abundance, while combinations exceeding a read count threshold of 65 are additionally highlighted by increased marker size to emphasize highly enriched species. (C) Chemical structures of the top enriched compounds identified from large-scale DEL screening. Enrichment was calculated as the ratio of nanopore sequencing read counts between target and control samples. For each core scaffold, the two compounds with the highest target-to-control enrichment are shown for both magnetic bead droplet and HeLa cell droplet screening conditions. The corresponding BB1-BB2-BB3-derived structures are displayed.

    Techniques Used: Nanopore Sequencing, Blocking Assay, Marker, Control, Derivative Assay

    Related Articles

    Plasmid Preparation:

    Article Title: NMR Analyses of Acetylated H2A.Z Isoforms Identify Differential Binding Interactions with the Bromodomain of the NURF Nucleosome Remodeling Complex
    Article Snippet: .. The pNIC28-Bsa4 plasmids containing the bromodomain of CECR2 (Addgene plasmid 39066; http://n2t.net/addgene:39066 ; RRID, Addgene_39066), the first bromodomains of BRD4 (Addgene plasmid 38943; http://n2t.net/addgene:38943 ; RRID, Addgene_38943) and BRDT (Addgene plasmid 38898; http://n2t.net/addgene:38898 ; RRID, Addgene_38898), and the second bromodomain of BRD2 (Addgene plasmid 39074; http://n2t.net/addgene:39074 ; RRID, Addgene_39074) were a kind gift from N. Burgess-Brown. .. Peptides were synthesized using standard N -9-fluorenylmethoxycarbonyl (Fmoc) solid phase synthesis methods on NovaSyn TGR resin (Novabiochem, 0.25 mmol/g) using a Liberty Blue automated microwave synthesizer and N , N ′-diisopropylcarbodiimide (DIC) and Oxyma for amino acid activation.

    Article Title: BPTF Target Engagement by Acetylated H2A.Z Photoaffinity Probes
    Article Snippet: .. 17 The pNIC28-Bsa4 plasmid containing the bromodomain of BPTF was a kind gift from S. Knapp (Nuffield Department of Medicine, University of Oxford, Oxford, U.K.) The pNIC28-Bsa4 plasmids containing the bromodomain of CECR2 (Addgene plasmid 39066; http://n2t.net/addgene:39066 ; RRID, Addgene_39066), the first bromodomains of BRD4 (Addgene plasmid 38943; http://n2t.net/addgene:38943 ; RRID, Addgene_38943), and the second bromodomain of BRD2 (Addgene plasmid 39074; http://n2t.net/addgene:39074 ; RRID, Addgene_39074) were a kind gift from N. Burgess-Brown. .. The pET28a(+) plasmid containing the first bromodomain of BRD2 (residues 71–194) and the second bromodomain of BRD4 (residues 333–460) was purchased from GenScript.

    Article Title: NMR Analyses of Acetylated H2A.Z Isoforms Identify Differential Binding Interactions with the Bromodomain of the NURF Nucleosome Remodeling Complex.
    Article Snippet: .. The pNIC28Bsa4 plasmids containing the bromodomain of CECR2 (Addgene plasmid 39066; http://n2t.net/addgene:39066; RRID, Addgene_39066), the first bromodomains of BRD4 (Addgene plasmid 38943; http://n2t.net/addgene:38943; RRID, Addgene_38943) and BRDT (Addgene plasmid 38898; http://n2t.net/addgene:38898; RRID, Addgene_38898), and the second bromodomain of BRD2 (Addgene plasmid 39074; http://n2t.net/addgene:39074; RRID, Addgene_39074) were a kind gift from N. BurgessBrown. .. The pET28a(+) plasmid containing the first bromodomain of BRD2 (residues 71−194), the second bromodomain of BRD4 (residues 333−460), and the PCAF bromodomain was purchased from GenScript.

    Article Title: DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia.
    Article Snippet: .. The genes encoding the bromodomains of human BRD2, BRD3, BRD4 and BRDT were PCR-amplified from the plasmids obtained from Addgene (plasmid no. 65376, 65377, 65378 and 65381, respectively). ..

    Polymerase Chain Reaction:

    Article Title: DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemia.
    Article Snippet: .. The genes encoding the bromodomains of human BRD2, BRD3, BRD4 and BRDT were PCR-amplified from the plasmids obtained from Addgene (plasmid no. 65376, 65377, 65378 and 65381, respectively). ..

    other:

    Article Title: NMR Analyses of Acetylated H2A.Z Isoforms Identify Differential Binding Interactions with the Bromodomain of the NURF Nucleosome Remodeling Complex
    Article Snippet: After incubation for 30 min in the dark, the plate was read in AlphaScreen mode using a PerkinElmer EnSpire plate reader.



    Similar Products

    86
    Twist Bioscience plasmodium falciparum gcn5 bromodomain
    Plasmodium Falciparum Gcn5 Bromodomain, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromodomains/bromodomain+falciparum+gcn5+plasmodium/pm41915381-30-1-16
    Average 86 stars, based on 1 article reviews
    plasmodium falciparum gcn5 bromodomain - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Eurofins bromomax bromodomain bromoscan leadhunter panel
    Bromomax Bromodomain Bromoscan Leadhunter Panel, supplied by Eurofins, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromodomains/bromodomain+bromomax+bromoscan+leadhunter+panel/pm42166816-493-8-13
    Average 86 stars, based on 1 article reviews
    bromomax bromodomain bromoscan leadhunter panel - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    91
    Addgene inc brd4 bromodomain plasmid
    (A) Chemical structure of the JQ1-oligo-Cy5 conjugate used as a fluorescent probe (BP). JQ1, a selective <t>BRD4</t> ligand, is covalently linked to a DNA oligonucleotide and a Cy5 fluorophore, allowing fluorescence-based detection of BRD4 binding. (B) Schematic illustrations (top) and corresponding fluorescence images (bottom) of agarose μ-droplets containing magnetic beads only, BRD4-bound magnetic beads, agarose alone, intact HeLa cells, or permeabilized HeLa cells after incubation with JQ1-oligo-Cy5. Strong Cy5 fluorescence was observed in droplets containing BRD4-bound magnetic beads and permeabilized HeLa cells, whereas no detectable Cy5 fluorescence was observed in magnetic beads only, intact HeLa cells, and agarose-only droplets. Scale bars, 50μm. (C) Schematic illustration of two-color Exchange-PAINT imaging using orthogonal DNA docking-imager strand pairs. An R6 docking strand conjugated to an anti-GFP nanobody was used to label GFP-BRD4, while an R2 docking strand was incorporated into the JQ1-based probe (JQ1-BP). Sequential super-resolution imaging was performed using R6* and R2* imager strands to independently localize BRD4 and bound JQ1, respectively. (D) Two-color Exchange-PAINT super-resolution images of GFP-BRD4-expressing Cos7 cells showing GFP-BRD4 (green) and the JQ1-based probe (JQ1-BP, red). Left, whole-nucleus view; middle, magnified view of the boxed region highlighting nanoscale clustering of BRD4 and JQ1. Right, the same region after Q-PAINT-based cluster filtering (K > 10), revealing higher-order nanoclusters containing both BRD4 and JQ1. Enrichment of JQ1-BP localizations at GFP-BRD4 clusters indicates that JQ1 preferentially localizes to BRD4-enriched nuclear regions.
    Brd4 Bromodomain Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromodomains/GFP-BRD4+(Plasmid+%2365378)/bio_rxiv__64898__2026__02__15__706034-167-1-17
    Average 91 stars, based on 1 article reviews
    brd4 bromodomain plasmid - by Bioz Stars, 2026-10
    91/100 stars
      Buy from Supplier

    86
    Eurofins bromodomain
    (A) Chemical structure of the JQ1-oligo-Cy5 conjugate used as a fluorescent probe (BP). JQ1, a selective <t>BRD4</t> ligand, is covalently linked to a DNA oligonucleotide and a Cy5 fluorophore, allowing fluorescence-based detection of BRD4 binding. (B) Schematic illustrations (top) and corresponding fluorescence images (bottom) of agarose μ-droplets containing magnetic beads only, BRD4-bound magnetic beads, agarose alone, intact HeLa cells, or permeabilized HeLa cells after incubation with JQ1-oligo-Cy5. Strong Cy5 fluorescence was observed in droplets containing BRD4-bound magnetic beads and permeabilized HeLa cells, whereas no detectable Cy5 fluorescence was observed in magnetic beads only, intact HeLa cells, and agarose-only droplets. Scale bars, 50μm. (C) Schematic illustration of two-color Exchange-PAINT imaging using orthogonal DNA docking-imager strand pairs. An R6 docking strand conjugated to an anti-GFP nanobody was used to label GFP-BRD4, while an R2 docking strand was incorporated into the JQ1-based probe (JQ1-BP). Sequential super-resolution imaging was performed using R6* and R2* imager strands to independently localize BRD4 and bound JQ1, respectively. (D) Two-color Exchange-PAINT super-resolution images of GFP-BRD4-expressing Cos7 cells showing GFP-BRD4 (green) and the JQ1-based probe (JQ1-BP, red). Left, whole-nucleus view; middle, magnified view of the boxed region highlighting nanoscale clustering of BRD4 and JQ1. Right, the same region after Q-PAINT-based cluster filtering (K > 10), revealing higher-order nanoclusters containing both BRD4 and JQ1. Enrichment of JQ1-BP localizations at GFP-BRD4 clusters indicates that JQ1 preferentially localizes to BRD4-enriched nuclear regions.
    Bromodomain, supplied by Eurofins, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromodomains/bromodomain/pm41671222-253-4-11
    Average 86 stars, based on 1 article reviews
    bromodomain - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    93
    Tocris bet bromodomain inhibitor jq1
    (A) Chemical structure of the JQ1-oligo-Cy5 conjugate used as a fluorescent probe (BP). JQ1, a selective <t>BRD4</t> ligand, is covalently linked to a DNA oligonucleotide and a Cy5 fluorophore, allowing fluorescence-based detection of BRD4 binding. (B) Schematic illustrations (top) and corresponding fluorescence images (bottom) of agarose μ-droplets containing magnetic beads only, BRD4-bound magnetic beads, agarose alone, intact HeLa cells, or permeabilized HeLa cells after incubation with JQ1-oligo-Cy5. Strong Cy5 fluorescence was observed in droplets containing BRD4-bound magnetic beads and permeabilized HeLa cells, whereas no detectable Cy5 fluorescence was observed in magnetic beads only, intact HeLa cells, and agarose-only droplets. Scale bars, 50μm. (C) Schematic illustration of two-color Exchange-PAINT imaging using orthogonal DNA docking-imager strand pairs. An R6 docking strand conjugated to an anti-GFP nanobody was used to label GFP-BRD4, while an R2 docking strand was incorporated into the JQ1-based probe (JQ1-BP). Sequential super-resolution imaging was performed using R6* and R2* imager strands to independently localize BRD4 and bound JQ1, respectively. (D) Two-color Exchange-PAINT super-resolution images of GFP-BRD4-expressing Cos7 cells showing GFP-BRD4 (green) and the JQ1-based probe (JQ1-BP, red). Left, whole-nucleus view; middle, magnified view of the boxed region highlighting nanoscale clustering of BRD4 and JQ1. Right, the same region after Q-PAINT-based cluster filtering (K > 10), revealing higher-order nanoclusters containing both BRD4 and JQ1. Enrichment of JQ1-BP localizations at GFP-BRD4 clusters indicates that JQ1 preferentially localizes to BRD4-enriched nuclear regions.
    Bet Bromodomain Inhibitor Jq1, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromodomains/(%2B)-JQ1/pmc12881557-262-1-7
    Average 93 stars, based on 1 article reviews
    bet bromodomain inhibitor jq1 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    EpiCypher 0313 gst brd2 bromodomain 1
    (A) Chemical structure of the JQ1-oligo-Cy5 conjugate used as a fluorescent probe (BP). JQ1, a selective <t>BRD4</t> ligand, is covalently linked to a DNA oligonucleotide and a Cy5 fluorophore, allowing fluorescence-based detection of BRD4 binding. (B) Schematic illustrations (top) and corresponding fluorescence images (bottom) of agarose μ-droplets containing magnetic beads only, BRD4-bound magnetic beads, agarose alone, intact HeLa cells, or permeabilized HeLa cells after incubation with JQ1-oligo-Cy5. Strong Cy5 fluorescence was observed in droplets containing BRD4-bound magnetic beads and permeabilized HeLa cells, whereas no detectable Cy5 fluorescence was observed in magnetic beads only, intact HeLa cells, and agarose-only droplets. Scale bars, 50μm. (C) Schematic illustration of two-color Exchange-PAINT imaging using orthogonal DNA docking-imager strand pairs. An R6 docking strand conjugated to an anti-GFP nanobody was used to label GFP-BRD4, while an R2 docking strand was incorporated into the JQ1-based probe (JQ1-BP). Sequential super-resolution imaging was performed using R6* and R2* imager strands to independently localize BRD4 and bound JQ1, respectively. (D) Two-color Exchange-PAINT super-resolution images of GFP-BRD4-expressing Cos7 cells showing GFP-BRD4 (green) and the JQ1-based probe (JQ1-BP, red). Left, whole-nucleus view; middle, magnified view of the boxed region highlighting nanoscale clustering of BRD4 and JQ1. Right, the same region after Q-PAINT-based cluster filtering (K > 10), revealing higher-order nanoclusters containing both BRD4 and JQ1. Enrichment of JQ1-BP localizations at GFP-BRD4 clusters indicates that JQ1 preferentially localizes to BRD4-enriched nuclear regions.
    0313 Gst Brd2 Bromodomain 1, supplied by EpiCypher, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromodomains/Nucleosome%2C+Recombinant+Human%2C+H4+Tetraacetyl+(H4K5%2C8%2C12%2C16ac)+dNuc%2C+Biotinylated/pm41478281-182-27-48
    Average 93 stars, based on 1 article reviews
    0313 gst brd2 bromodomain 1 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc extraterminal domain brd4 bromodomain
    (A) Chemical structure of the JQ1-oligo-Cy5 conjugate used as a fluorescent probe (BP). JQ1, a selective <t>BRD4</t> ligand, is covalently linked to a DNA oligonucleotide and a Cy5 fluorophore, allowing fluorescence-based detection of BRD4 binding. (B) Schematic illustrations (top) and corresponding fluorescence images (bottom) of agarose μ-droplets containing magnetic beads only, BRD4-bound magnetic beads, agarose alone, intact HeLa cells, or permeabilized HeLa cells after incubation with JQ1-oligo-Cy5. Strong Cy5 fluorescence was observed in droplets containing BRD4-bound magnetic beads and permeabilized HeLa cells, whereas no detectable Cy5 fluorescence was observed in magnetic beads only, intact HeLa cells, and agarose-only droplets. Scale bars, 50μm. (C) Schematic illustration of two-color Exchange-PAINT imaging using orthogonal DNA docking-imager strand pairs. An R6 docking strand conjugated to an anti-GFP nanobody was used to label GFP-BRD4, while an R2 docking strand was incorporated into the JQ1-based probe (JQ1-BP). Sequential super-resolution imaging was performed using R6* and R2* imager strands to independently localize BRD4 and bound JQ1, respectively. (D) Two-color Exchange-PAINT super-resolution images of GFP-BRD4-expressing Cos7 cells showing GFP-BRD4 (green) and the JQ1-based probe (JQ1-BP, red). Left, whole-nucleus view; middle, magnified view of the boxed region highlighting nanoscale clustering of BRD4 and JQ1. Right, the same region after Q-PAINT-based cluster filtering (K > 10), revealing higher-order nanoclusters containing both BRD4 and JQ1. Enrichment of JQ1-BP localizations at GFP-BRD4 clusters indicates that JQ1 preferentially localizes to BRD4-enriched nuclear regions.
    Extraterminal Domain Brd4 Bromodomain, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromodomains/pm41430687-192-34-61
    Average 86 stars, based on 1 article reviews
    extraterminal domain brd4 bromodomain - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Orient Bio Company female bromodomain factor 1 bdf 1 mice
    (A) Chemical structure of the JQ1-oligo-Cy5 conjugate used as a fluorescent probe (BP). JQ1, a selective <t>BRD4</t> ligand, is covalently linked to a DNA oligonucleotide and a Cy5 fluorophore, allowing fluorescence-based detection of BRD4 binding. (B) Schematic illustrations (top) and corresponding fluorescence images (bottom) of agarose μ-droplets containing magnetic beads only, BRD4-bound magnetic beads, agarose alone, intact HeLa cells, or permeabilized HeLa cells after incubation with JQ1-oligo-Cy5. Strong Cy5 fluorescence was observed in droplets containing BRD4-bound magnetic beads and permeabilized HeLa cells, whereas no detectable Cy5 fluorescence was observed in magnetic beads only, intact HeLa cells, and agarose-only droplets. Scale bars, 50μm. (C) Schematic illustration of two-color Exchange-PAINT imaging using orthogonal DNA docking-imager strand pairs. An R6 docking strand conjugated to an anti-GFP nanobody was used to label GFP-BRD4, while an R2 docking strand was incorporated into the JQ1-based probe (JQ1-BP). Sequential super-resolution imaging was performed using R6* and R2* imager strands to independently localize BRD4 and bound JQ1, respectively. (D) Two-color Exchange-PAINT super-resolution images of GFP-BRD4-expressing Cos7 cells showing GFP-BRD4 (green) and the JQ1-based probe (JQ1-BP, red). Left, whole-nucleus view; middle, magnified view of the boxed region highlighting nanoscale clustering of BRD4 and JQ1. Right, the same region after Q-PAINT-based cluster filtering (K > 10), revealing higher-order nanoclusters containing both BRD4 and JQ1. Enrichment of JQ1-BP localizations at GFP-BRD4 clusters indicates that JQ1 preferentially localizes to BRD4-enriched nuclear regions.
    Female Bromodomain Factor 1 Bdf 1 Mice, supplied by Orient Bio Company, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromodomains/1+1+bdf+bromodomain+factor+female+mice/pmc12682407-55-1-7
    Average 86 stars, based on 1 article reviews
    female bromodomain factor 1 bdf 1 mice - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    96
    Selleck Chemicals bromodomain inhibitor
    (A) Chemical structure of the JQ1-oligo-Cy5 conjugate used as a fluorescent probe (BP). JQ1, a selective <t>BRD4</t> ligand, is covalently linked to a DNA oligonucleotide and a Cy5 fluorophore, allowing fluorescence-based detection of BRD4 binding. (B) Schematic illustrations (top) and corresponding fluorescence images (bottom) of agarose μ-droplets containing magnetic beads only, BRD4-bound magnetic beads, agarose alone, intact HeLa cells, or permeabilized HeLa cells after incubation with JQ1-oligo-Cy5. Strong Cy5 fluorescence was observed in droplets containing BRD4-bound magnetic beads and permeabilized HeLa cells, whereas no detectable Cy5 fluorescence was observed in magnetic beads only, intact HeLa cells, and agarose-only droplets. Scale bars, 50μm. (C) Schematic illustration of two-color Exchange-PAINT imaging using orthogonal DNA docking-imager strand pairs. An R6 docking strand conjugated to an anti-GFP nanobody was used to label GFP-BRD4, while an R2 docking strand was incorporated into the JQ1-based probe (JQ1-BP). Sequential super-resolution imaging was performed using R6* and R2* imager strands to independently localize BRD4 and bound JQ1, respectively. (D) Two-color Exchange-PAINT super-resolution images of GFP-BRD4-expressing Cos7 cells showing GFP-BRD4 (green) and the JQ1-based probe (JQ1-BP, red). Left, whole-nucleus view; middle, magnified view of the boxed region highlighting nanoscale clustering of BRD4 and JQ1. Right, the same region after Q-PAINT-based cluster filtering (K > 10), revealing higher-order nanoclusters containing both BRD4 and JQ1. Enrichment of JQ1-BP localizations at GFP-BRD4 clusters indicates that JQ1 preferentially localizes to BRD4-enriched nuclear regions.
    Bromodomain Inhibitor, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bromodomains/(%2B)-JQ1/pmc12664489-356-20-22
    Average 96 stars, based on 1 article reviews
    bromodomain inhibitor - by Bioz Stars, 2026-10
    96/100 stars
      Buy from Supplier

    Image Search Results


    (A) Chemical structure of the JQ1-oligo-Cy5 conjugate used as a fluorescent probe (BP). JQ1, a selective BRD4 ligand, is covalently linked to a DNA oligonucleotide and a Cy5 fluorophore, allowing fluorescence-based detection of BRD4 binding. (B) Schematic illustrations (top) and corresponding fluorescence images (bottom) of agarose μ-droplets containing magnetic beads only, BRD4-bound magnetic beads, agarose alone, intact HeLa cells, or permeabilized HeLa cells after incubation with JQ1-oligo-Cy5. Strong Cy5 fluorescence was observed in droplets containing BRD4-bound magnetic beads and permeabilized HeLa cells, whereas no detectable Cy5 fluorescence was observed in magnetic beads only, intact HeLa cells, and agarose-only droplets. Scale bars, 50μm. (C) Schematic illustration of two-color Exchange-PAINT imaging using orthogonal DNA docking-imager strand pairs. An R6 docking strand conjugated to an anti-GFP nanobody was used to label GFP-BRD4, while an R2 docking strand was incorporated into the JQ1-based probe (JQ1-BP). Sequential super-resolution imaging was performed using R6* and R2* imager strands to independently localize BRD4 and bound JQ1, respectively. (D) Two-color Exchange-PAINT super-resolution images of GFP-BRD4-expressing Cos7 cells showing GFP-BRD4 (green) and the JQ1-based probe (JQ1-BP, red). Left, whole-nucleus view; middle, magnified view of the boxed region highlighting nanoscale clustering of BRD4 and JQ1. Right, the same region after Q-PAINT-based cluster filtering (K > 10), revealing higher-order nanoclusters containing both BRD4 and JQ1. Enrichment of JQ1-BP localizations at GFP-BRD4 clusters indicates that JQ1 preferentially localizes to BRD4-enriched nuclear regions.

    Journal: bioRxiv

    Article Title: Microfluidic Agarose µ -Droplets for DNA-Encoded Chemical Library Screening

    doi: 10.64898/2026.02.15.706034

    Figure Lengend Snippet: (A) Chemical structure of the JQ1-oligo-Cy5 conjugate used as a fluorescent probe (BP). JQ1, a selective BRD4 ligand, is covalently linked to a DNA oligonucleotide and a Cy5 fluorophore, allowing fluorescence-based detection of BRD4 binding. (B) Schematic illustrations (top) and corresponding fluorescence images (bottom) of agarose μ-droplets containing magnetic beads only, BRD4-bound magnetic beads, agarose alone, intact HeLa cells, or permeabilized HeLa cells after incubation with JQ1-oligo-Cy5. Strong Cy5 fluorescence was observed in droplets containing BRD4-bound magnetic beads and permeabilized HeLa cells, whereas no detectable Cy5 fluorescence was observed in magnetic beads only, intact HeLa cells, and agarose-only droplets. Scale bars, 50μm. (C) Schematic illustration of two-color Exchange-PAINT imaging using orthogonal DNA docking-imager strand pairs. An R6 docking strand conjugated to an anti-GFP nanobody was used to label GFP-BRD4, while an R2 docking strand was incorporated into the JQ1-based probe (JQ1-BP). Sequential super-resolution imaging was performed using R6* and R2* imager strands to independently localize BRD4 and bound JQ1, respectively. (D) Two-color Exchange-PAINT super-resolution images of GFP-BRD4-expressing Cos7 cells showing GFP-BRD4 (green) and the JQ1-based probe (JQ1-BP, red). Left, whole-nucleus view; middle, magnified view of the boxed region highlighting nanoscale clustering of BRD4 and JQ1. Right, the same region after Q-PAINT-based cluster filtering (K > 10), revealing higher-order nanoclusters containing both BRD4 and JQ1. Enrichment of JQ1-BP localizations at GFP-BRD4 clusters indicates that JQ1 preferentially localizes to BRD4-enriched nuclear regions.

    Article Snippet: The BRD4 bromodomain plasmid (pHis-BRD4 BD1, item #196544), GFP-BRD4 expression plasmid (GFP-BRD4, item #65378) was obtained from Addgene (Watertown, MA, USA).

    Techniques: Fluorescence, Binding Assay, Magnetic Beads, Incubation, Imaging, Expressing

    (A) Composition of the four-compound library used for proof-of-concept DEL screening, including JQ1 as a positive control, GL-CBS and methotrexate (MTX) as off-target binders, and benzoic acid as a negative control. (B) Enrichment ratios (Target / Control) derived from nanopore sequencing data following small-scale DEL screening in agarose μ-droplets containing BRD4-bound magnetic beads (target) or magnetic beads only (control). JQ1 exhibited strong enrichment above the threshold (Target / Control = 1), whereas other compounds showed minimal enrichment. (C) Quantitative analysis of small-scale DEL screening performed in cell-containing agarose μ-droplets, in which DEL enrichment was quantified by qPCR following screening. Agarose-only μ-droplets were used as a control condition, while μ-droplets containing permeabilized HeLa cells or BRD4-overexpressing HeLa cells were treated as target conditions. JQ1 showed the highest enrichment among tested compounds and displayed a pronounced preference for BRD4-overexpressing HeLa cells compared to permeabilized cells. Representative bright field, emGFP, and Cy5 fluorescence images are shown on the right. Scale bars, 50μm. emGFP fluorescence was observed specifically in BRD4-overexpressing HeLa cells. As both HeLa cell conditions were permeabilized, Cy5 fluorescence originating from BP was detected in droplets containing either permeabilized or BRD4-overexpressing HeLa cells.

    Journal: bioRxiv

    Article Title: Microfluidic Agarose µ -Droplets for DNA-Encoded Chemical Library Screening

    doi: 10.64898/2026.02.15.706034

    Figure Lengend Snippet: (A) Composition of the four-compound library used for proof-of-concept DEL screening, including JQ1 as a positive control, GL-CBS and methotrexate (MTX) as off-target binders, and benzoic acid as a negative control. (B) Enrichment ratios (Target / Control) derived from nanopore sequencing data following small-scale DEL screening in agarose μ-droplets containing BRD4-bound magnetic beads (target) or magnetic beads only (control). JQ1 exhibited strong enrichment above the threshold (Target / Control = 1), whereas other compounds showed minimal enrichment. (C) Quantitative analysis of small-scale DEL screening performed in cell-containing agarose μ-droplets, in which DEL enrichment was quantified by qPCR following screening. Agarose-only μ-droplets were used as a control condition, while μ-droplets containing permeabilized HeLa cells or BRD4-overexpressing HeLa cells were treated as target conditions. JQ1 showed the highest enrichment among tested compounds and displayed a pronounced preference for BRD4-overexpressing HeLa cells compared to permeabilized cells. Representative bright field, emGFP, and Cy5 fluorescence images are shown on the right. Scale bars, 50μm. emGFP fluorescence was observed specifically in BRD4-overexpressing HeLa cells. As both HeLa cell conditions were permeabilized, Cy5 fluorescence originating from BP was detected in droplets containing either permeabilized or BRD4-overexpressing HeLa cells.

    Article Snippet: The BRD4 bromodomain plasmid (pHis-BRD4 BD1, item #196544), GFP-BRD4 expression plasmid (GFP-BRD4, item #65378) was obtained from Addgene (Watertown, MA, USA).

    Techniques: Drug discovery, Positive Control, Negative Control, Control, Derivative Assay, Nanopore Sequencing, Magnetic Beads, Fluorescence

    (A) Aggregated nanopore sequencing read count distributions for each core scaffold across four screening conditions: magnetic bead–only droplets, BRD4-bound magnetic bead droplets, permeabilized HeLa cell droplets, and BRD4-overexpressing HeLa cell droplets. The DNA-encoded library consisted of three distinct core scaffolds (pyrimidine, trifunctional benzene, and chiral proline cores), each comprising a 96 × 96 × 96 combinatorial spaces. (B) Three-dimensional enrichment maps for each core scaffold across the four screening conditions, displaying the top 200 BB1–BB2–BB3 combinations ranked by nanopore sequencing read count. Each axis (x, y, and z) corresponds to one building block position (BB1, BB2, and BB3), and individual points represent distinct BB1– BB2–BB3 combinations. Point color indicates read count abundance, while combinations exceeding a read count threshold of 65 are additionally highlighted by increased marker size to emphasize highly enriched species. (C) Chemical structures of the top enriched compounds identified from large-scale DEL screening. Enrichment was calculated as the ratio of nanopore sequencing read counts between target and control samples. For each core scaffold, the two compounds with the highest target-to-control enrichment are shown for both magnetic bead droplet and HeLa cell droplet screening conditions. The corresponding BB1-BB2-BB3-derived structures are displayed.

    Journal: bioRxiv

    Article Title: Microfluidic Agarose µ -Droplets for DNA-Encoded Chemical Library Screening

    doi: 10.64898/2026.02.15.706034

    Figure Lengend Snippet: (A) Aggregated nanopore sequencing read count distributions for each core scaffold across four screening conditions: magnetic bead–only droplets, BRD4-bound magnetic bead droplets, permeabilized HeLa cell droplets, and BRD4-overexpressing HeLa cell droplets. The DNA-encoded library consisted of three distinct core scaffolds (pyrimidine, trifunctional benzene, and chiral proline cores), each comprising a 96 × 96 × 96 combinatorial spaces. (B) Three-dimensional enrichment maps for each core scaffold across the four screening conditions, displaying the top 200 BB1–BB2–BB3 combinations ranked by nanopore sequencing read count. Each axis (x, y, and z) corresponds to one building block position (BB1, BB2, and BB3), and individual points represent distinct BB1– BB2–BB3 combinations. Point color indicates read count abundance, while combinations exceeding a read count threshold of 65 are additionally highlighted by increased marker size to emphasize highly enriched species. (C) Chemical structures of the top enriched compounds identified from large-scale DEL screening. Enrichment was calculated as the ratio of nanopore sequencing read counts between target and control samples. For each core scaffold, the two compounds with the highest target-to-control enrichment are shown for both magnetic bead droplet and HeLa cell droplet screening conditions. The corresponding BB1-BB2-BB3-derived structures are displayed.

    Article Snippet: The BRD4 bromodomain plasmid (pHis-BRD4 BD1, item #196544), GFP-BRD4 expression plasmid (GFP-BRD4, item #65378) was obtained from Addgene (Watertown, MA, USA).

    Techniques: Nanopore Sequencing, Blocking Assay, Marker, Control, Derivative Assay